Atlas Trials

First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras

Clinical trial NCT01057017 · TERMINATED

Trial details

NCT number
NCT01057017
Sponsor
Brown University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2010-01-01
Primary completion
2011-04-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.